Penobscot Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$774K Sell
13,428
-350
-3% -$20.1K 0.05% 187
2026
Q1
$836K Sell
13,778
-800
-5% -$46.6K 0.07% 182
2025
Q4
$786K Sell
14,578
-500
-3% -$24.1K 0.06% 188
2025
Q3
$680K Sell
15,078
-540
-3% -$25.2K 0.05% 197
2025
Q2
$723K Buy
15,618
+126
+0.8% +$6.18K 0.06% 186
2025
Q1
$945K Buy
15,492
+862
+6% +$50.2K 0.09% 163
2024
Q4
$827K Sell
14,630
-498
-3% -$27.8K 0.08% 171
2024
Q3
$783K Sell
15,128
-76
-0.5% -$3.56K 0.07% 177
2024
Q2
$631K Sell
15,204
-1,294
-8% -$57.9K 0.06% 186
2024
Q1
$895K Sell
16,498
-1,939
-11% -$98.8K 0.09% 160
2023
Q4
$946K Buy
18,437
+600
+3% +$31.5K 0.11% 153
2023
Q3
$1.04M Buy
17,837
+6,992
+64% +$428K 0.14% 127
2023
Q2
$694K Hold
10,845
0.11% 133
2023
Q1
$752K Hold
10,845
0.13% 125
2022
Q4
$780K Hold
10,845
0.14% 126
2022
Q3
$771K Hold
10,845
0.14% 123
2022
Q2
$836K Sell
10,845
-2,260
-17% -$172K 0.14% 124
2022
Q1
$957K Buy
13,105
+2,050
+19% +$138K 0.14% 130
2021
Q4
$689K Hold
11,055
0.09% 150
2021
Q3
$655K Sell
11,055
-78
-0.7% -$5.14K 0.1% 152
2021
Q2
$744K Sell
11,133
-4,000
-26% -$261K 0.11% 146
2021
Q1
$955K Sell
15,133
-90
-0.6% -$5.6K 0.15% 122
2020
Q4
$944K Hold
15,223
0.16% 117
2020
Q3
$918K Sell
15,223
-777
-5% -$46.8K 0.17% 108
2020
Q2
$941K Hold
16,000
0.19% 104
2020
Q1
$892K Buy
16,000
+830
+5% +$50.7K 0.21% 99
2019
Q4
$973K Buy
15,170
+520
+4% +$29.8K 0.18% 110
2019
Q3
$743K Hold
14,650
0.15% 122
2019
Q2
$664K Hold
14,650
0.14% 124
2019
Q1
$699K Sell
14,650
-80
-0.5% -$3.98K 0.15% 122
2018
Q4
$766K Sell
14,730
-1,000
-6% -$53.7K 0.18% 110
2018
Q3
$977K Hold
15,730
0.21% 105
2018
Q2
$870K Hold
15,730
0.2% 108
2018
Q1
$995K Buy
15,730
+3,875
+33% +$249K 0.24% 102
2017
Q4
$726K Sell
11,855
-200
-2% -$12.5K 0.2% 104
2017
Q3
$768K Hold
12,055
0.23% 98
2017
Q2
$672K Sell
12,055
-20
-0.2% -$1.09K 0.22% 100
2017
Q1
$657K Sell
12,075
-2,050
-15% -$112K 0.22% 98
2016
Q4
$825K Hold
14,125
0.29% 89
2016
Q3
$762K Sell
14,125
-500
-3% -$32.1K 0.27% 92
2016
Q2
$1.08M Sell
14,625
-630
-4% -$44.5K 0.38% 79
2016
Q1
$974K Sell
15,255
-2,200
-13% -$139K 0.36% 82
2015
Q4
$1.2M Buy
17,455
+850
+5% +$56.2K 0.38% 78
2015
Q3
$983K Hold
16,605
0.33% 83
2015
Q2
$1.1M Buy
16,605
+735
+5% +$48.4K 0.34% 81
2015
Q1
$1.02M Hold
15,870
0.32% 84
2014
Q4
$937K Sell
15,870
-900
-5% -$50.8K 0.29% 86
2014
Q3
$858K Sell
16,770
-72
-0.4% -$3.6K 0.28% 86
2014
Q2
$817K Sell
16,842
-1,930
-10% -$95.1K 0.27% 87
2014
Q1
$975K Sell
18,772
-150
-0.8% -$7.98K 0.35% 78
2013
Q4
$1.01M Buy
18,922
+900
+5% +$45.8K 0.36% 78
2013
Q3
$834K Buy
18,022
+1,300
+8% +$57.1K 0.33% 77
2013
Q2
$747K Buy
+16,722
New +$726K 0.31% 79

Other funds holding BMY

Penobscot Investment Management's BMY Position: Q2 2026 in Review

Penobscot Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, selling an estimated $20.1K and leaving 13,428 shares worth $774K. The position accounts for 0.05% of the portfolio, ranked #187.

Penobscot Investment Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.2M in Q4 2015. 949 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Penobscot Investment Management held 13,428 shares of Bristol-Myers Squibb worth $774K as of Q2 2026.
  • Penobscot Investment Management sold 350 Bristol-Myers Squibb shares in Q2 2026, an estimated $20.1K.
  • Bristol-Myers Squibb made up 0.05% of Penobscot Investment Management's portfolio in Q2 2026, its #187 holding.
  • Penobscot Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Penobscot Investment Management's Bristol-Myers Squibb position peaked at $1.2M in Q4 2015.
  • 949 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.